IFN-γ and TNF-α treated mesenchymal stem cells can enhance the chemotherapy resistance of colon cancer cells
CSTR:
Author:
Affiliation:

Tumor Immunology and Gene Therapy Center,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Department of Phamacy,Changhai Hospital,the Second Military Medical University,Central Laboratory,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Tumor Immunology and Gene Therapy Center,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Department of Phamacy,Changhai Hospital,the Second Military Medical University,Tumor Immunology and Gene Therapy Center,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To observe the influence of interferon-γ(IFN-γ)and tumor necrosis factor-α(TNF-α)treated mesenchymal stem cells (MSCs) on the chemotherapy resistance of colon cancer cells(CRCs) and to discuss the related mechanism. Methods The supernatants of MSCs treated with IFN-γ and TNF-α were collected and used, together with chemotherapy drug cisplatin and 5-fluorouracil, to treat HCT116 and HT29 CRCs. Then the cellular morphology was observed under microscope, and the cell proliferation and apoptosis were examined by MTT and PI/Annexin Ⅴ-FITC assay. Furthermore, the mRNA levels of Bax and Bcl-2 were detected by RT-PCR. Results The CRCs treated with the supernatant of MSCs exposed to inflammatory factors, compared to CRCs treated with the supernatant of MSCs not exposed to inflammatory factors, had a slighter morphology changes, a significantly higher proliferation rate (P<0.05), and a significantly lower apoptosis rate following chemotherapy(P<0.05). Moreover, Bcl-2 mRNA level was higher and Bax mRNA level was lower in CRCs treated with the supernatant of MSCs exposed to inflammatory factors. Conclusion MSCs stimulated with inflammation factors IFN-γ and TNF-α can promote the chemotherapy resistance of human CRCs.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 22,2015
  • Revised:October 26,2015
  • Adopted:December 15,2015
  • Online: January 22,2016
  • Published:
Article QR Code